Sangamo Therapeutics, Inc. (SGMO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Sangamo Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.96x | -2.10x | -0.37x | -2.52x | -6.08x | -17.34x |
| P/B Ratio | -8.25x | 9.04x | 1.14x | 1.64x | 2.89x | 4.21x |
| P/S Ratio | 2.98x | 3.56x | 0.54x | 4.35x | 9.79x | 17.75x |
| Profitability | ||||||
| Gross Margin | 80.8% | 100.0% | 100.0% | 89.1% | 100.0% | -52.8% |
| Operating Margin | -273.1% | -179.9% | -155.5% | -180.8% | -165.6% | -109.6% |
| Net Margin | -310.8% | -169.4% | -146.3% | -172.8% | -161.1% | -102.4% |
| EBITDA Margin | -253.8% | -154.1% | -54.9% | -170.0% | -149.7% | -104.8% |
| Liquidity | ||||||
| Current Ratio | 0.84x | 1.13x | 1.98x | 2.69x | 3.12x | 4.60x |
| Quick Ratio | 0.84x | 1.13x | 1.98x | 2.69x | 3.12x | 4.60x |
| Leverage | ||||||
| Debt/Equity | -1.88x | 1.34x | 0.46x | 0.15x | 0.13x | 0.08x |
YoY = year-over-year change. Source: FMP..